Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with paclitaxel resistance
- 9 November 2009
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 3 (11) , 1288-1295
Abstract
Paclitaxel has been widely used as an anti‐mitotic agent in chemotherapy for a variety of cancers and adds substantial efficacy as the first‐line chemotherapeutic regimen for ovarian cancers. However, the frequent occurrence of paclitaxel resistance limits its function in long‐term management. Despite abundant clinical and cellular demonstration of paclitaxel resistant tumors, the molecular mechanisms leading to paclitaxel resistance are poorly understood. Using genomic approaches, we have previously identified an association between a BTB/POZ gene, NAC1, and paclitaxel resistance in ovarian cancer. The experiments presented here have applied multiple quantitative proteomic methods to identify protein changes associated with paclitaxel resistance and NAC1 function. The SKOV‐3 ovarian serous carcinoma cell line, which has inducible expression of dominant‐negative NAC1, was used to determine the paclitaxel treatment associated changes in the presence and absence of functional NAC1. Quantitative proteomic analyses were performed using iTRAQ labeling and MS. Two label‐free quantitative proteomic methods: LC‐MS and spectral count were used to increase confidence of proteomic quantification. Candidate proteins related to paclitaxel and NAC1 function were identified in this study. Gene ontology analysis of the protein changes identified upon paclitaxel resistance revealed that cell component enrichment related to mitochondria. Moreover, tubulin and mitochondrial proteins were the major cellular components with changes associated with paclitaxel treatment. This suggests that mitochondria may play a role in paclitaxel resistance.Keywords
Funding Information
- National Cancer Institute (R21-CA-114852)
- National Institutes of Health (RO1-CA-103937 (IMS))
- Early Detection and Research Network
- Mass Spectrometry Facility at the Johns Hopkins University
- Applied Biosystems
This publication has 37 references indexed in Scilit:
- NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathwayOncogene, 2009
- Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respirationProceedings of the National Academy of Sciences, 2008
- VDAC regulation: role of cytosolic proteins and mitochondrial lipidsJournal of Bioenergetics and Biomembranes, 2008
- Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope DilutionMolecular & Cellular Proteomics, 2007
- Capture and analysis of quantitative proteomic dataProteomics, 2007
- A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survivalProceedings of the National Academy of Sciences, 2006
- Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging ReagentsMolecular & Cellular Proteomics, 2004
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002
- Taxol ResistanceChemotherapy, 2000
- An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein databaseJournal of the American Society for Mass Spectrometry, 1994